MicroRNAs as pharmacological targets in cancer

Pharmacological Research

Volumn 75, Issue , 2013, Pages 3-14

  Soriano, Aroa ^a   Jubierre, Luz ^a   Almazán Moga, Ana ^a   Molist, Carla ^a   Roma, Josep ^a   De Toledo, José Sánchez ^a   Gallego, Soledad ^a   Segura, Miguel F ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Antimirs; Cancer therapy; microRNA; miRNA mimetics

Indexed keywords

DOCETAXEL; LET 7; LET 7A; LET 7B; LET 7C; MICRORNA; MICRORNA 10B; MICRORNA 122; MICRORNA 132; MICRORNA 135B; MICRORNA 143; MICRORNA 145; MICRORNA 155; MICRORNA 16; MICRORNA 17 5P; MICRORNA 17 92; MICRORNA 182; MICRORNA 19; MICRORNA 21; MICRORNA 221; MICRORNA 26A; MICRORNA 34; MICRORNA 34A; MICRORNA 375; MICRORNA 380 5P; MICRORNA 7; MICRORNA 9; PACLITAXEL; TRASTUZUMAB; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; BLADDER CANCER; BREAST CANCER; BREAST TUMOR; COLON CANCER; COLORECTAL CANCER; ERBB POSITIVE BREAST CANCER; HODGKIN DISEASE; LARGE CELL LYMPHOMA; LEUKEMIA; LIVER CELL CARCINOMA; LIVER MELANOMA METASTASIS; LIVER TUMOR; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LYMPHOMA; MELANOMA; MELANOMA METASTASIS; NEUROBLASTOMA; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CARCINOMA; SOFT TISSUE SARCOMA;

ANTIMIRS; CANCER THERAPY; MICRORNA; MIRNA MIMETICS;

ANIMALS; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENETIC THERAPY; HUMANS; MICRORNAS; NEOPLASMS;

EID: 84884815937     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.03.006     Document Type: Review

References (172)

1. J.E. Visvader, and G.J. Lindeman Cancer stem cells: current status and evolving complexities Cell Stem Cell 6 10 2012 717 728
2. J.E. Visvader Cells of origin in cancer Nature 7330 469 2011 314 322
3. M. Tan, and D. Yu Molecular mechanisms of erbB2-mediated breast cancer chemoresistance Advances in Experimental Medicine and Biology 608 2007 119 129
4. E.H. Romond, E.A. Perez, J. Bryant, V.J. Suman, C.E. Geyer Jr., and N.E. Davidson Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer New England Journal of Medicine 16 353 2005 1673 1684 (Pubitemid 41464706)
5. M.J. Piccart-Gebhart, M. Procter, B. Leyland-Jones, A. Goldhirsch, M. Untch, and I. Smith Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer New England Journal of Medicine 16 353 2005 1659 1672 (Pubitemid 41464705)
6. C. Gambacorti-Passerini, L. Antolini, F.X. Mahon, F. Guilhot, M. Deininger, and C. Fava Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib Journal of the National Cancer Institute 7 103 2011 553 561
7. C.D. Blanke, G.D. Demetri, M. von Mehren, M.C. Heinrich, B. Eisenberg, and J.A. Fletcher Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT Journal of Clinical Oncology 4 26 2008 620 625 (Pubitemid 351264357)
8. G. Bollag, P. Hirth, J. Tsai, J. Zhang, P.N. Ibrahim, and H. Cho Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma Nature 7315 467 2010 596 599
9. R. Nazarian, H. Shi, Q. Wang, X. Kong, R.C. Koya, and H. Lee Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation Nature 468 7326 2010 973 977
10. Y. Lee, M. Kim, J. Han, K.H. Yeom, S. Lee, and S.H. Baek MicroRNA genes are transcribed by RNA polymerase II EMBO Journal 20 23 2004 4051 4060 (Pubitemid 39472426)
11. G.M. Borchert, W. Lanier, and B.L. Davidson RNA polymerase III transcribes human microRNAs Nature Structural & Molecular Biology 12 13 2006 1097 1101 (Pubitemid 44885920)
12. V.N. Kim, and J.W. Nam Genomics of microRNA Trends in Genetics 3 22 2006 165 173 (Pubitemid 43290020)
13. B. Czech, and G.J. Hannon Small RNA sorting: matchmaking for Argonautes Nature Reviews Genetics 1 12 2011 19 31
14. J.G. Ruby, C.H. Jan, and D.P. Bartel Intronic microRNA precursors that bypass Drosha processing Nature 7149 448 2007 83 86 (Pubitemid 47037009)
15. C.W. Park, Y. Zeng, X. Zhang, S. Subramanian, and C.J. Steer Mature microRNAs identified in highly purified nuclei from HCT116 colon cancer cells RNA Biology 5 7 2010 606 614
16. R. Yi, Y. Qin, I.G. Macara, and B.R. Cullen Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs Genes and Development 24 17 2003 3011 3016 (Pubitemid 38040764)
17. Y. Lee, K. Jeon, J.T. Lee, S. Kim, and V.N. Kim MicroRNA maturation: stepwise processing and subcellular localization EMBO Journal 17 21 2002 4663 4670 (Pubitemid 34984353)
18. K. Okamura, M.D. Phillips, D.M. Tyler, H. Duan, Y.T. Chou, and E.C. Lai The regulatory activity of microRNA* species has substantial influence on microRNA and 3′ UTR evolution Nature Structural & Molecular Biology 4 15 2008 354 363 (Pubitemid 351483397)
19. S. Griffiths-Jones, J.H. Hui, A. Marco, and M. Ronshaugen MicroRNA evolution by arm switching EMBO Reports 2 12 2011 172 177
20. I. Lee, S.S. Ajay, J.I. Yook, H.S. Kim, S.H. Hong, and N.H. Kim New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites Genome Research 7 19 2009 1175 1183
21. J.R. Lytle, T.A. Yario, and J.A. Steitz Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR Proceedings of the National Academy of Sciences of the United States of America 23 104 2007 9667 9672 (Pubitemid 47175324)
22. Y. Tay, J. Zhang, A.M. Thomson, B. Lim, and I. Rigoutsos MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation Nature 7216 455 2008 1124 1128
23. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 2 136 2009 215 233
24. M.M. Janas, and C.D. Novina Not lost in translation: stepwise regulation of microRNA targets EMBO Journal 11 31 2012 2446 2447
25. S. Majid, A.A. Dar, S. Saini, S. Yamamura, H. Hirata, and Y. Tanaka MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer Cancer 24 116 2010 5637 5649
26. A.M. Eiring, J.G. Harb, P. Neviani, C. Garton, J.J. Oaks, and R. Spizzo miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts Cell 5 140 2010 652 665
27. M. Beitzinger, and G. Meister Preview. MicroRNAs: from decay to decoy Cell 5 140 2010 612 614
28. G.A. Calin, C.D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, and E. Noch Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia Proceedings of the National Academy of Sciences of the United States of America 24 99 2002 15524 15529 (Pubitemid 35403967)
29. L. Zhang, J. Huang, N. Yang, J. Greshock, M.S. Megraw, and A. Giannakakis microRNAs exhibit high frequency genomic alterations in human cancer Proceedings of the National Academy of Sciences of the United States of America 24 103 2006 9136 9141 (Pubitemid 43902545)
30. D.G. Albertson, C. Collins, F. McCormick, and J.W. Gray Chromosome aberrations in solid tumors Nature Genetics 4 34 2003 369 376 (Pubitemid 36935328)
31. A. Weith, T. Martinsson, C. Cziepluch, S. Bruderlein, L.C. Amler, and F. Berthold Neuroblastoma consensus deletion maps to 1p36.1-2 Genes, Chromosomes and Cancer 2 1 1989 159 166 (Pubitemid 20094561)
32. I. Leister, A. Weith, S. Bruderlein, C. Cziepluch, D. Kangwanpong, and P. Schlag Human colorectal cancer: high frequency of deletions at chromosome 1p35 Cancer Research 22 50 1990 7232 7235
33. I. Bieche, M.H. Champeme, F. Matifas, C.S. Cropp, R. Callahan, and R. Lidereau Two distinct regions involved in 1p deletion in human primary breast cancer Cancer Research 9 53 1993 1990 1994 (Pubitemid 23145715)
34. T.J. Herzog, L.D. Kowalski, H. Liu, M. Arlt, and E. Swisher Evaluation of a region on chromosome 1p in ovarian serous carcinoma that is frequently deleted in uterine papillary serous carcinoma Gynecologic Oncology 1 82 2001 139 142 (Pubitemid 32634966)
35. A.G. Bader miR-34 - a microRNA replacement therapy is headed to the clinic Frontiers in Genetics 3 2012 120
36. H. Hermeking The miR-34 family in cancer and apoptosis Cell Death and Differentiation 2 17 2010 193 199
37. M. Vita, and M. Henriksson The Myc oncoprotein as a therapeutic target for human cancer Seminars in Cancer Biology 4 16 2006 318 330 (Pubitemid 44311040)
38. T.C. Chang, D. Yu, Y.S. Lee, E.A. Wentzel, D.E. Arking, and K.M. West Widespread microRNA repression by Myc contributes to tumorigenesis Nature Genetics 1 40 2008 43 50
39. M.J. Bueno, M. Gomez de Cedron, G. Gomez-Lopez, I. Perez de Castro, L. Di Lisio, and S. Montes-Moreno Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway Blood 23 117 2011 6255 6266
40. A. Lujambio, and M. Esteller CpG island hypermethylation of tumor suppressor microRNAs in human cancer Cell Cycle 12 6 2007 1455 1459
41. M.S. Kumar, J. Lu, K.L. Mercer, T.R. Golub, and T. Jacks Impaired microRNA processing enhances cellular transformation and tumorigenesis Nature Genetics 5 39 2007 673 677 (Pubitemid 46676103)
42. Y. Karube, H. Tanaka, H. Osada, S. Tomida, Y. Tatematsu, and K. Yanagisawa Reduced expression of Dicer associated with poor prognosis in lung cancer patients Cancer Science 2 96 2005 111 115 (Pubitemid 40425386)
43. W.M. Merritt, Y.G. Lin, L.Y. Han, A.A. Kamat, W.A. Spannuth, and R. Schmandt Dicer, Drosha, and outcomes in patients with ovarian cancer New England Journal of Medicine 25 359 2008 2641 2650
44. G. Grelier, N. Voirin, A.S. Ay, D.G. Cox, S. Chabaud, and I. Treilleux Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype British Journal of Cancer 4 101 2009 673 683
45. J.W. Catto, S. Miah, H.C. Owen, H. Bryant, K. Myers, and E. Dudziec Distinct microRNA alterations characterize high- and low-grade bladder cancer Cancer Research 21 69 2009 8472 8481
46. R.J. Lin, Y.C. Lin, J. Chen, H.H. Kuo, Y.Y. Chen, and M.B. Diccianni microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma Cancer Research 20 70 2010 7841 7850
47. M.D. Martin Gingival Nikolsky's sign is useful for clinical diagnosis Journal of Evidence-Based Dental Practice 4 9 2009 217 218
48. D.X. Zhu, L. Fan, R.N. Lu, C. Fang, W.Y. Shen, and Z.J. Zou Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia Cancer Science 5 103 2012 875 881
49. S. Chiosea, E. Jelezcova, U. Chandran, M. Acquafondata, T. McHale, and R.W. Sobol Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma American Journal of Pathology 5 169 2006 1812 1820 (Pubitemid 351182010)
50. V. D'Ambrosio, E. Nagali, C.H. Monken, S. Slussarenko, L. Marrucci, and F. Sciarrino Deterministic qubit transfer between orbital and spin angular momentum of single photons Organic Letters 2 37 2012 172 174
51. D.J. Papachristou, U.N. Rao, A. Korpetinou, E. Giannopoulou, E. Sklirou, and V. Kontogeorgakos Prognostic significance of Dicer cellular levels in soft tissue sarcomas Cancer Investigation 2 30 2012 172 179
52. Z. Ma, H. Swede, D. Cassarino, E. Fleming, A. Fire, and S.S. Dadras Up-regulated Dicer expression in patients with cutaneous melanoma PLoS ONE 6 6 2011 e20494
53. C. Faber, D. Horst, F. Hlubek, and T. Kirchner Overexpression of Dicer predicts poor survival in colorectal cancer European Journal of Cancer 9 47 2011 1414 1419
54. S.A. Melo, S. Ropero, C. Moutinho, L.A. Aaltonen, H. Yamamoto, and G.A. Calin A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function Nature Genetics 3 41 2009 365 370
55. S.A. Melo, C. Moutinho, S. Ropero, G.A. Calin, S. Rossi, and R. Spizzo A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells Cancer Cell 4 18 2010 303 315
56. M.A. Newman, J.M. Thomson, and S.M. Hammond Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing RNA 8 14 2008 1539 1549
57. T. Fukuda, K. Yamagata, S. Fujiyama, T. Matsumoto, I. Koshida, and K. Yoshimura DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs Nature Cell Biology 5 9 2007 604 611 (Pubitemid 46696543)
58. M.A. Carmell, Z. Xuan, M.Q. Zhang, and G.J. Hannon The Argonaute family: tentacles that reach into RNAi, developmental control, stem cell maintenance, and tumorigenesis Genes and Development 21 16 2002 2733 2742 (Pubitemid 35253139)
59. D.W. Salzman, J. Shubert-Coleman, and H. Furneaux P68 RNA helicase unwinds the human let-7 microRNA precursor duplex and is required for let-7-directed silencing of gene expression Journal of Biological Chemistry 45 282 2007 32773 32779 (Pubitemid 350159271)
60. D. Wang, J. Huang, and Z. Hu RNA helicase DDX5 regulates microRNA expression and contributes to cytoskeletal reorganization in basal breast cancer cells Molecular and Cellular Proteomics 2 11 2012 M111.011932
61. M. van Kouwenhove, M. Kedde, and R. Agami MicroRNA regulation by RNA-binding proteins and its implications for cancer Nature Reviews Cancer 9 11 2011 644 656
62. M. Kedde, M.J. Strasser, B. Boldajipour, J.A. Oude Vrielink, K. Slanchev, and C. le Sage RNA-binding protein Dnd1 inhibits microRNA access to target mRNA Cell 7 131 2007 1273 1286
63. G. Solda, M. Robusto, P. Primignani, P. Castorina, E. Benzoni, and A. Cesarani A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing Human Molecular Genetics 3 21 2012 577 585
64. Z. Zhu, W. Gao, Z. Qian, and Y. Miao Genetic variation of miRNA sequence in pancreatic cancer Acta Biochimica et Biophysica Sinica (Shanghai) 5 41 2009 407 413
65. A.E. Hughes, D.T. Bradley, M. Campbell, J. Lechner, D.P. Dash, and D.A. Simpson Mutation altering the miR-184 seed region causes familial keratoconus with cataract American Journal of Human Genetics 5 89 2011 628 633
66. A. Clop, F. Marcq, H. Takeda, D. Pirottin, X. Tordoir, and B. Bibe A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep Nature Genetics 7 38 2006 813 818 (Pubitemid 43980603)
67. P.J. Mishra, R. Humeniuk, P.J. Mishra, G.S. Longo-Sorbello, D. Banerjee, and J.R. Bertino A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance Proceedings of the National Academy of Sciences of the United States of America 33 104 2007 13513 13518 (Pubitemid 47293976)
68. P.I. Poulikakos, C. Zhang, G. Bollag, K.M. Shokat, and N. Rosen RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF Nature 7287 464 2010 427 430
69. E. van Rooij, L.B. Sutherland, X. Qi, J.A. Richardson, J. Hill, and E.N. Olson Control of stress-dependent cardiac growth and gene expression by a microRNA Science 5824 316 2007 575 579 (Pubitemid 46683138)
70. A.L. Kasinski, and F.J. Slack Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy Nature Reviews Cancer 12 11 2011 849 864
71. S. Gilad, E. Meiri, Y. Yogev, S. Benjamin, D. Lebanony, and N. Yerushalmi Serum microRNAs are promising novel biomarkers PLoS ONE 9 3 2008 e3148
72. P.S. Mitchell, R.K. Parkin, E.M. Kroh, B.R. Fritz, S.K. Wyman, and E.L. Pogosova-Agadjanyan Circulating microRNAs as stable blood-based markers for cancer detection Proceedings of the National Academy of Sciences of the United States of America 30 105 2008 10513 10518
73. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J.J. Lee, and J.O. Lotvall Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nature Cell Biology 6 9 2007 654 659 (Pubitemid 47214727)
74. M.P. Hunter, N. Ismail, X. Zhang, B.D. Aguda, E.J. Lee, and L. Yu Detection of microRNA expression in human peripheral blood microvesicles PLoS ONE 11 3 2008 e3694
75. Y. Xi, G. Nakajima, E. Gavin, C.G. Morris, K. Kudo, and K. Hayashi Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples RNA 10 13 2007 1668 1674 (Pubitemid 47481675)
76. S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, and F. Petrocca A microRNA expression signature of human solid tumors defines cancer gene targets Proceedings of the National Academy of Sciences of the United States of America 7 103 2006 2257 2261 (Pubitemid 43271657)
77. X. Pan, Z.X. Wang, and R. Wang MicroRNA-21: a novel therapeutic target in human cancer Cancer Biology and Therapy 12 10 2010 1224 1232
78. P.P. Medina, M. Nolde, and F.J. Slack OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma Nature 7311 467 2010 86 90
79. M.E. Hatley, D.M. Patrick, M.R. Garcia, J.A. Richardson, R. Bassel-Duby, and E. van Rooij Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21 Cancer Cell 3 18 2010 282 293
80. B. Lankat-Buttgereit, and R. Goke Programmed cell death protein 4 (pdcd4): a novel target for antineoplastic therapy? Biology of the Cell 8 95 2003 515 519 (Pubitemid 37461481)
81. H. Allgayer Pdcd4, a colon cancer prognostic that is regulated by a microRNA Critical Reviews in Oncology/Hematology 3 73 2010 185 191
82. M.R. Young, A.N. Santhanam, N. Yoshikawa, and N.H. Colburn Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue? Molecular Interventions 2 10 2010 76 79
83. A. Rodriguez, E. Vigorito, S. Clare, M.V. Warren, P. Couttet, and D.R. Soond Requirement of bic/microRNA-155 for normal immune function Science 5824 316 2007 608 611 (Pubitemid 46683148)
84. S. Costinean, N. Zanesi, Y. Pekarsky, E. Tili, S. Volinia, and N. Heerema Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice Proceedings of the National Academy of Sciences of the United States of America 18 103 2006 7024 7029
85. I. Faraoni, F.R. Antonetti, J. Cardone, and E. Bonmassar miR-155 gene: a typical multifunctional microRNA Biomedica Biochimica Acta 6 1792 2009 497 505
86. S. Jiang, H.W. Zhang, M.H. Lu, X.H. He, Y. Li, and H. Gu MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene Cancer Research 8 70 2010 3119 3127
87. L.M. Pouliot, Y.C. Chen, J. Bai, R. Guha, S.E. Martin, and M.M. Gottesman Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family Cancer Research 22 72 2010 5945 5955
88. Y.S. Zang, Y.F. Zhong, Z. Fang, B. Li, and J. An MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression Cancer Gene Therapy 11 19 2012 773 778
89. A. Ota, H. Tagawa, S. Karnan, S. Tsuzuki, A. Karpas, and S. Kira Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma Cancer Research 9 64 2004 3087 3095 (Pubitemid 38581408)
90. V. Olive, I. Jiang, and L. He mir-17-92, a cluster of miRNAs in the midst of the cancer network International Journal of Biochemistry and Cell Biology 8 42 2010 1348 1354
91. I. Ibarra, Y. Erlich, S.K. Muthuswamy, R. Sachidanandam, and G.J. Hannon A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells Genes and Development 24 21 2007 3238 3243 (Pubitemid 350277751)
92. B. Boyerinas, S.M. Park, A. Hau, A.E. Murmann, and M.E. Peter The role of let-7 in cell differentiation and cancer Endocrine-related Cancer 1 17 2010 F19 F36
93. G.A. Calin, C. Sevignani, C.D. Dumitru, T. Hyslop, E. Noch, and S. Yendamuri Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proceedings of the National Academy of Sciences of the United States of America 9 101 2004 2999 3004 (Pubitemid 38327724)
94. J.M. Thomson, M. Newman, J.S. Parker, E.M. Morin-Kensicki, T. Wright, and S.M. Hammond Extensive post-transcriptional regulation of microRNAs and its implications for cancer Genes and Development 16 20 2006 2202 2207
95. S.R. Viswanathan, J.T. Powers, W. Einhorn, Y. Hoshida, T.L. Ng, and S. Toffanin Lin28 promotes transformation and is associated with advanced human malignancies Nature Genetics 7 41 2009 843 848
96. Y. Huang A mirror of two faces: Lin28 as a master regulator of both miRNA and mRNA Wiley Interdisciplinary Review RNA 4 3 2012 483 494
97. A. Esquela-Kerscher, P. Trang, J.F. Wiggins, L. Patrawala, A. Cheng, and L. Ford The let-7 microRNA reduces tumor growth in mouse models of lung cancer Cell Cycle 6 7 2008 759 764 (Pubitemid 351520040)
98. C.D. Johnson, A. Esquela-Kerscher, G. Stefani, M. Byrom, K. Kelnar, and D. Ovcharenko The let-7 microRNA represses cell proliferation pathways in human cells Cancer Research 16 67 2007 7713 7722 (Pubitemid 47281364)
99. C. Mayr, M.T. Hemann, and D.P. Bartel Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation Science 5818 315 2007 1576 1579 (Pubitemid 46449474)
100. K.A. Cole, E.F. Attiyeh, Y.P. Mosse, M.J. Laquaglia, S.J. Diskin, and G.M. Brodeur A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene Molecular Cancer Research 5 6 2008 735 742
101. D. Lodygin, V. Tarasov, A. Epanchintsev, C. Berking, T. Knyazeva, and H. Korner Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer Cell Cycle 16 7 2008 2591 2600
102. M. Vogt, J. Munding, M. Gruner, S.T. Liffers, B. Verdoodt, and J. Hauk Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas Virchows Archiv 3 458 2011 313 322
103. H. Hermeking p53 enters the microRNA world Cancer Cell 5 12 2007 414 418 (Pubitemid 350046413)
104. M.Z.S.MO.C. Michael, N.G. van Holst Pellekaan, G.P. Young, and R.J. James Reduced accumulation of specific microRNAs in colorectal neoplasia Molecular Cancer Research 12 1 2003 882 891 (Pubitemid 37288707)
105. Y. Akao, Y. Nakagawa, Y. Kitade, T. Kinoshita, and T. Naoe Downregulation of microRNAs-143 and -145 in B-cell malignancies Cancer Science 12 98 2007 1914 1920 (Pubitemid 350002197)
106. J.H. Ohyashiki, K. Ohyashiki, A.A. Sandberg, J. Minowada, and A.J. Kinniburgh Human-fms gene is retained in acute lymphoblastic leukemia cells with del(5)(q32) Cancer Genetics and Cytogenetics 2 25 1987 341 350 (Pubitemid 17057647)
107. M. Sachdeva, S. Zhu, F. Wu, H. Wu, V. Walia, and S. Kumar p53 represses c-Myc through induction of the tumor suppressor miR-145 Proceedings of the National Academy of Sciences of the United States of America 9 106 2009 3207 3212
108. A. Pagliuca, C. Valvo, E. Fabrizi, S. di Martino, M. Biffoni, and D. Runci Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression Oncogene 2012 Nov 5
109. H. Zhang, X. Cai, Y. Wang, H. Tang, D. Tong, and F. Ji microRNA-143, down-regulated in osteosarcoma, promotes apoptosis and suppresses tumorigenicity by targeting Bcl-2 Oncology Reports 5 24 2010 1363 1369
110. J. Weiler, J. Hunziker, and J. Hall Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Therapy 6 13 2006 496 502
111. L. Fontana, M.E. Fiori, S. Albini, L. Cifaldi, S. Giovinazzi, and M. Forloni Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM PLoS ONE 5 3 2008 e2236
112. F. Felicetti, M.C. Errico, P. Segnalini, G. Mattia, and A. Care MicroRNA-221 and -222 pathway controls melanoma progression Expert Review of Anticancer Therapy 11 8 2008 1759 1765
113. N. Mercatelli, V. Coppola, D. Bonci, F. Miele, A. Costantini, and M. Guadagnoli The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice PLoS ONE 12 3 2008 e4029
114. J.H. Schulte, S. Horn, T. Otto, B. Samans, L.C. Heukamp, and U.C. Eilers MYCN regulates oncogenic microRNAs in neuroblastoma International Journal of Cancer 3 122 2008 699 704 (Pubitemid 350308967)
115. A. Swarbrick, S.L. Woods, A. Shaw, A. Balakrishnan, Y. Phua, and A. Nguyen miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma Nature Medicine 10 16 2010 1134 1140
116. B. Vester, and J. Wengel LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA Biochemistry 42 43 2004 13233 13241 (Pubitemid 39391124)
117. L. Ma, F. Reinhardt, E. Pan, J. Soutschek, B. Bhat, and E.G. Marcusson Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model Nature Biotechnology 4 28 2010 341 347
118. H. Matsuyama, H.I. Suzuki, H. Nishimori, M. Noguchi, T. Yao, and N. Komatsu miR-135b mediates NPM-ALK-driven oncogenicity and renders IL-17-producing immunophenotype to anaplastic large cell lymphoma Blood 26 118 2011 6881 6892
119. Y. Zhang, A.M. Roccaro, C. Rombaoa, L. Flores, S. Obad, and S.M. Fernandes LNA-mediated anti-miR-155 silencing in low-grade B-cell lymphomas Blood 8 120 2012 1678 1686
120. S. Obad, C.O. dos Santos, A. Petri, M. Heidenblad, O. Broom, and C. Ruse Silencing of microRNA families by seed-targeting tiny LNAs Nature Genetics 4 43 2011 371 378
121. E. Leucci, A. Zriwil, L.H. Gregersen, K.T. Jensen, S. Obad, and C. Bellan Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo Oncogene 31 49 2012 5081 5089
122. J. Xiao, B. Yang, H. Lin, Y. Lu, X. Luo, and Z. Wang Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4 Journal of Cellular Physiology 2 212 2007 285 292 (Pubitemid 47025616)
123. W.Y. Choi, A.J. Giraldez, and A.F. Schier Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430 Science 5848 318 2007 271 274 (Pubitemid 47574854)
124. R. Garzon, G. Marcucci, and C.M. Croce Targeting microRNAs in cancer: rationale, strategies and challenges Nature Reviews Drug Discovery 10 9 2010 775 789
125. S. Anand, B.K. Majeti, L.M. Acevedo, E.A. Murphy, R. Mukthavaram, and L. Scheppke MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis Nature Medicine 8 16 2010 909 914
126. B.L. Davidson, and P.B. McCray Jr. Current prospects for RNA interference-based therapies Nature Reviews Genetics 5 12 2011 329 340
127. S. Xiang, J. Fruehauf, and C.J. Li Short hairpin RNA-expressing bacteria elicit RNA interference in mammals Nature Biotechnology 6 24 2006 697 702 (Pubitemid 43882121)
128. C. Huynh, M.F. Segura, A. Gaziel-Sovran, S. Menendez, F. Darvishian, and L. Chiriboga Efficient in vivo microRNA targeting of liver metastasis Oncogene 12 30 2011 1481 1488
129. D.M. Pereira, P.M. Rodrigues, P.M. Borralho, and C.M. Rodrigues Delivering the promise of miRNA cancer therapeutics Drug Discovery Today 18 5-6 2013 282 289
130. J.C. Henry, A.C. Azevedo-Pouly, and T.D. Schmittgen MicroRNA replacement therapy for cancer Pharmaceutical Research 12 28 2011 3030 3042
131. H. Tazawa, N. Tsuchiya, M. Izumiya, and H. Nakagama Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells Proceedings of the National Academy of Sciences of the United States of America 39 104 2007 15472 15477 (Pubitemid 47502941)
132. F. Takeshita, L. Patrawala, M. Osaki, R.U. Takahashi, Y. Yamamoto, and N. Kosaka Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes Molecular Therapy 1 18 2010 181 187
133. Y. Chen, X. Zhu, X. Zhang, B. Liu, and L. Huang Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy Molecular Therapy 9 18 2010 1650 1656
134. D. Pramanik, N.R. Campbell, C. Karikari, R. Chivukula, O.A. Kent, and J.T. Mendell Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice Molecular Cancer Therapeutics 8 10 2011 1470 1480
135. K. Rai, N. Takigawa, S. Ito, H. Kashihara, E. Ichihara, and T. Yasuda Liposomal delivery of MicroRNA-7-expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer cells Molecular Cancer Therapeutics 9 10 2011 1720 1727
136. C.V. Pecot, G.A. Calin, R.L. Coleman, G. Lopez-Berestein, and A.K. Sood RNA interference in the clinic: challenges and future directions Nature Reviews Cancer 1 11 2011 59 67
137. V.J. Craig, S.B. Cogliatti, J. Imig, C. Renner, S. Neuenschwander, and H. Rehrauer Myc-mediated repression of microRNA-34a promotes high-grade transformation of B-cell lymphoma by dysregulation of FoxP1 Blood 23 117 2011 6227 6236
138. J.F. Wiggins, L. Ruffino, K. Kelnar, M. Omotola, L. Patrawala, and D. Brown Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 Cancer Research 14 70 2010 5923 5930
139. P. Trang, J.F. Wiggins, C.L. Daige, C. Cho, M. Omotola, and D. Brown Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice Molecular Therapy 6 19 2010 1116 1122
140. G.Y. Chiou, J.Y. Cherng, H.S. Hsu, M.L. Wang, C.M. Tsai, and K.H. Lu Cationic polyurethanes-short branch PEI-mediated delivery of Mir145 inhibited epithelial-mesenchymal transdifferentiation and cancer stem-like properties and in lung adenocarcinoma Journal of Controlled Release 2 159 2012 240 250
141. A. Tivnan, W.S. Orr, V. Gubala, R. Nooney, D.E. Williams, and C. McDonagh Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles PLoS ONE 5 7 2012 e38129
142. N. Nadiminty, R. Tummala, W. Lou, Y. Zhu, X.B. Shi, and J.X. Zou MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth PLoS ONE 3 7 2012 e32832
143. J. Kota, R.R. Chivukula, K.A. O'Donnell, E.A. Wentzel, C.L. Montgomery, and H.W. Hwang Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model Cell 6 137 2009 1005 1017
144. J. Tabernero, G.I. Shapiro, P.M. Lorusso, A. Cervantes, G.K. Schwartz, and G.J. Weiss First-in-man trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement Cancer Discovery January 2013
145. P.E. Blower, J.S. Verducci, S. Lin, J. Zhou, J.H. Chung, and Z. Dai MicroRNA expression profiles for the NCI-60 cancer cell panel Molecular Cancer Therapeutics 5 6 2007 1483 1491 (Pubitemid 46954015)
146. A. Kanakkanthara, and J.H. Miller MicroRNAs: novel mediators of resistance to microtubule-targeting agents Cancer Treatment and Research 2 39 2012 161 170
147. W. Rui, F. Bing, S. Hai-Zhu, D. Wei, and C. Long-Bang Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1) Journal of Cellular and Molecular Medicine 1-2 14 2010 206 214
148. B. Feng, R. Wang, and L.B. Chen MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1 Cancer Letters 2 317 2012 184 191
149. B.J. Henson, S. Bhattacharjee, D.M. O'Dee, E. Feingold, and S.M. Gollin Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy Genes, Chromosomes and Cancer 7 48 2009 569 582
150. W. Shi, N.M. Alajez, C. Bastianutto, A.B. Hui, J.D. Mocanu, and E. Ito Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer International Journal of Cancer 9 126 2010 2036 2048
151. J.C. Oliveira, M.S. Brassesco, A.G. Morales, J.A. Pezuk, P.F. Fedatto, and G.N. da Silva MicroRNA-100 acts as a tumor suppressor in human bladder carcinoma 5637 cells Asian Pacific Journal of Cancer Prevention 11 12 2011 3001 3004
152. L. Huang, J.X. Lin, Y.H. Yu, M.Y. Zhang, H.Y. Wang, and M. Zheng Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix PLoS ONE 3 7 2012 e33762
153. J. Liu, K.H. Lu, Z.L. Liu, M. Sun, W. De, and Z.X. Wang MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1 BMC Cancer 1 12 2012 519
154. A. Petrelli, A. Perra, K. Schernhuber, M. Cargnelutti, A. Salvi, and C. Migliore Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression Oncogene 42 31 2012 4517 4526
155. Z. Liang, Y. Li, K. Huang, N. Wagar, and H. Shim Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN Pharmaceutical Research 12 28 2011 3091 3100
156. D.M. Cittelly, I. Dimitrova, E.N. Howe, D.R. Cochrane, A. Jean, and N.S.
157. P.S. Mongroo, and A.K. Rustgi The role of the miR-200 family in epithelial-mesenchymal transition Cancer Biology and Therapy 3 10 2010 219 222
158. R. Mathew, V. Karantza-Wadsworth, and E. White Role of autophagy in cancer Nature Reviews Cancer 12 7 2007 961 967 (Pubitemid 350165856)
159. H. Zhu, H. Wu, X. Liu, B. Li, Y. Chen, and X. Ren Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells Autophagy 6 5 2009 816 823
160. Z. Zou, L. Wu, H. Ding, Y. Wang, Y. Zhang, and X. Chen MicroRNA-30a sensitizes tumor cells to cis-platinum via suppressing beclin 1-mediated autophagy Journal of Biological Chemistry 6 287 2012 4148 4156
161. A. Baraniskin, K. Birkenkamp-Demtroder, A. Maghnouj, H. Zollner, J. Munding, and S. Klein-Scory MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL Carcinogenesis 4 33 2012 732 739
162. R. Kumarswamy, G. Mudduluru, P. Ceppi, S. Muppala, M. Kozlowski, and J. Niklinski MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer International Journal of Cancer 9 130 2012 2044 2053
163. D. Yan, W.L. Ng, X. Zhang, P. Wang, Z. Zhang, and Y.Y. Mo Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation PLoS ONE 7 5 2010 e11397
164. Z. Liang, J. Ahn, D. Guo, J.R. Votaw, and H. Shim MicroRNA-302 replacement therapy sensitizes breast cancer cells to ionizing radiation Pharmaceutical Research 30 4 2013 1008 1016
165. A.C. Wolff, M.E. Hammond, J.N. Schwartz, K.L. Hagerty, D.C. Allred, and R.J. Cote American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer Journal of Clinical Oncology 1 25 2007 118 145 (Pubitemid 350003059)
166. F.J. Esteva, V. Valero, D. Booser, L.T. Guerra, J.L. Murray, and L. Pusztai Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer Journal of Clinical Oncology 7 20 2002 1800 1808 (Pubitemid 34273269)
167. C. Gong, Y. Yao, Y. Wang, B. Liu, W. Wu, and J. Chen Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer Journal of Biological Chemistry 21 286 2011 19127 19137
168. E. van Rooij, A.L. Purcell, and A.A. Levin Developing microRNA therapeutics Circulation Research 3 110 2012 496 507
169. X. Zhang, S. Liu, T. Hu, S. Liu, Y. He, and S. Sun Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression Hepatology 2 50 2009 490 499
170. I.A. Babar, C.J. Cheng, C.J. Booth, X. Liang, J.B. Weidhaas, and W.M. Saltzman Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma Proceedings of the National Academy of Sciences of the United States of America 109 26 2012 E1695 E1704
171. P. Trang, P.P. Medina, J.F. Wiggins, L. Ruffino, K. Kelnar, and M. Omotola Regression of murine lung tumors by the let-7 microRNA Oncogene 29 11 2010 1580 1587
172. X.X. He, Y. Chang, F.Y. Meng, M.Y. Wang, Q.H. Xie, and F. Tang MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo Oncogene 31 28 2012 3357 3369